Ultragenyx Pharmaceutical | RARE - بدهی های جاری

قیمت سهام
19.87
تغییر روزانه
-0.55 -2.69%
ماهیانه
-11.73%
سالیانه
-49.29%
Q1 پیش بینی
19.27




بدهی های جاری تغییر دادن تاریخ
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Immunic USD 30.08M 2.77M 2025-09
Insmed USD 468.87M 51.66M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Kyowa Hakko Kirin JPY 181.08B 4.08B 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Moderna USD 1.99B 306M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Xoma USD 28.3M 6.81M 2025-09